Benzinga | Aug 11, 2020 04:06PM EDT

Agile Therapeutics Q2 EPS $(0.12) Beats $(0.14) Estimate

Agile Therapeutics (NASDAQ:AGRX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 50 percent decrease over losses of $(0.08) per share from the same period last year.